Tradestie Institutional Equity Comparison Engine
RENX vs AIMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AIMD Overall Edge
AIMD Captures Institutional Edge (3โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ainos, Inc. Common Stock (AIMD) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RENX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AIMD at 13.9x Forward P/E and -101210.2% operating margin (-96.7% YoY). In options structure, RENX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AIMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AIMD
RENX N/M vs AIMD 13.9x Fwd P/E
Growth & Margin Winner
AIMD
Op Margin N/A vs -101210.2% ยท YoY N/A vs -96.7%
Momentum & Technical Winner
AIMD
1Y +163.6% vs -41.6% ยท 52W Pos 19% vs 22%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RENX
US Equity
RENX
Institutional Equity
$0.74
-23.09% 1D
Market Cap
N/A
1M Return
-48.21%
1Y Return
+163.59%
Forward P/E
N/M
Unified AI Score
44.0 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 64.0
AIMD
NASDAQ
Ainos, Inc. Common Stock
Pharmaceutical Preparations
$1.18
+6.31% 1D
Market Cap
$8.4M
1M Return
+39.79%
1Y Return
-41.58%
Forward P/E
13.9x
Unified AI Score
23.4 / 100
STRONG SELL
Tech 50.0
Fund 31.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RENX +163.59%
AIMD -41.58%
Spread: +207.66 pp (RENX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RENX TTM Op. Margin: N/A
AIMD TTM Op. Margin: -101210.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RENX vs AIMD. Trailing 12-month operating profitability (RENX N/A vs AIMD -101210.2%) and valuation multiples (RENX N/M vs AIMD 13.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RENX | AIMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $8.4M | Larger Scale | AIMD |
| Trailing P/E Ratio Valuation | N/M | 13.9x | Lower Multiple | AIMD |
| Forward P/E Ratio Valuation | N/M | 13.9x | Lower Multiple | AIMD |
| Revenue Growth (YoY) Growth | N/A | -96.7% | Higher Growth | AIMD |
| Operating Margin (TTM) Profitability | N/A | -101210.2% | Higher Margin | AIMD |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | AIMD |
| Return on Equity (ROE) Capital Efficiency | N/A | -196.3% | Higher ROE | AIMD |
| 52-Week Range Position Momentum | 19% ($0โ$3) | 22% ($0โ$4) | Stronger Trend | AIMD |
| Beta / 30D Volatility Risk Regime | -17.85ฮฒ ยท 161% Vol | 2.03ฮฒ ยท 437% Vol | Lower Realized Risk | RENX |
| Unified Institutional Score Composite Signal | 44.0 / 100 (HOLD) | 23.4 / 100 (STRONG SELL) | Higher Composite | RENX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RENX vs AIMD Buy Guide
RENX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AIMD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RENX nor AIMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.